These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10595730)

  • 1. Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
    Iwasa T; Takano T; Hara K; Kamei T
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):325-30. PubMed ID: 10595730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-format-based solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry.
    Kolocouri F; Dotsikas Y; Apostolou C; Kousoulos C; Loukas YL
    Anal Bioanal Chem; 2007 Jan; 387(2):593-601. PubMed ID: 17119933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS/MS.
    Shah HJ; Kundlik ML; Patel NK; Subbaiah G; Patel DM; Suhagia BN; Patel CN
    J Sep Sci; 2009 Oct; 32(20):3388-94. PubMed ID: 19750501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
    Polinko M; Riffel K; Song H; Lo MW
    J Pharm Biomed Anal; 2003 Sep; 33(1):73-84. PubMed ID: 12946533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.
    Yeung PK; Jamieson A; Smith GJ; Fice D; Pollak PT
    Int J Pharm; 2000 Aug; 204(1-2):17-22. PubMed ID: 11011981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
    Liu D; Jiang J; Wang P; Feng S; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):743-8. PubMed ID: 20153270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standard.
    Prasaja B; Sasongko L; Harahap Y; Hardiyanti ; Lusthom W; Grigg M
    J Pharm Biomed Anal; 2009 Apr; 49(3):862-7. PubMed ID: 19217738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
    Farthing D; Sica D; Fakhry I; Pedro A; Gehr TW
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):374-8. PubMed ID: 9518174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots.
    Rao RN; Raju SS; Vali RM; Sankar GG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():47-54. PubMed ID: 22770781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
    Soldner A; Spahn-Langguth H; Mutschler E
    J Pharm Biomed Anal; 1998 Jan; 16(5):863-73. PubMed ID: 9535198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic interaction chromatography-tandem mass spectrometric analysis of irbesartan in human plasma: application to pharmacokinetic study of irbesartan.
    Lee HW; Ji HY; Park ES; Lee KC; Lee HS
    J Sep Sci; 2009 Jul; 32(14):2353-8. PubMed ID: 19536783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
    Furtek CI; Lo MW
    J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
    Oh KS; Park SJ; Shinde DD; Shin JG; Kim DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():56-64. PubMed ID: 22483397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection.
    Vlase L; Imre S; Muntean D; Leucuta SE
    J Pharm Biomed Anal; 2007 Jul; 44(3):652-7. PubMed ID: 16962733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of compound danshen tablet on the pharmacokinetics of losartan and its metabolite EXP3174 by liquid chromatography coupled with mass spectrometry.
    Yuan Y; Zhang H; Ma W; Sun S; Wang B; Zhao L; Zhang G; Chai Y
    Biomed Chromatogr; 2013 Sep; 27(9):1219-24. PubMed ID: 23722257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of vardenafil and its major metabolite, N-desethylvardenafil, in human plasma: application to a pharmacokinetic study.
    Ku HY; Shon JH; Liu KH; Shin JG; Bae SK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(1-2):95-100. PubMed ID: 19042162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
    Zhou Y; Li H; He X; Jia M; Ni Y; Xu M; Chen H; Li W
    J Pharm Biomed Anal; 2014 Nov; 100():294-299. PubMed ID: 25194342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of moxonidine in human plasma by liquid chromatography-electrospray ionisation-mass spectrometry.
    Zhao L; Ding L; Wei X
    J Pharm Biomed Anal; 2006 Jan; 40(1):95-9. PubMed ID: 16011885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography - tandem mass spectrometry for the simultaneous quantitation of glipizide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in rat plasma: application for a pharmacokinetic study.
    Satheeshmanikandan TR; Sridhar V; Kanthikiran VV; Swaroopkumar VV; Mukkanti K
    Arzneimittelforschung; 2012 Sep; 62(9):425-32. PubMed ID: 22821721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Determination and Pharmacokinetics of Metolazone, Losartan and Losartan Carboxylic Acid in Rat Plasma by HPLC-ESI-MS-MS.
    Dubey R; Ghosh M; Sinha BN; Muthukrishnan V
    J Chromatogr Sci; 2015 Oct; 53(9):1520-7. PubMed ID: 25947361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.